Indaptus Therapeutics (INDP) SEC Filings: History & Chart

Indaptus Therapeutics, Inc.(INDP)

Biotechnology · New York City, NY

$2.57+0.06 (+2.39%)

Delayed quote: Oct 6, 2026, 2:40 PM EDT

About Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under the name Intec Parent, Inc., the company officially rebranded to Indaptus Therapeutics, Inc. in August of the same year. Its corporate headquarters are situated in New York, New York.

New York City, NY

5 employees

indaptusrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Junyi Dai

View full financials

Form	Filing Date	Accepted	Document
S-8	Oct 5, 2026	Oct 5, 2026	View filing
8-K	Sep 30, 2026	Sep 30, 2026	View filing
8-K	Sep 10, 2026	Sep 9, 2026	View filing
8-K/A	Sep 8, 2026	Sep 4, 2026	View filing
8-K	Sep 4, 2026	Sep 4, 2026	View filing
424B5	Sep 4, 2026	Sep 4, 2026	View filing
8-K	Sep 1, 2026	Sep 1, 2026	View filing
424B5	Aug 31, 2026	Aug 31, 2026	View filing
424B3	Aug 26, 2026	Aug 26, 2026	View filing
EFFECT	Aug 25, 2026	Aug 26, 2026	View filing
S-3	Aug 17, 2026	Aug 17, 2026	View filing
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
EFFECT	Jul 17, 2026	Jul 20, 2026	View filing
DEF 14A	Jul 16, 2026	Jul 16, 2026	View filing
SC 13D/A	Jun 26, 2026	Jun 26, 2026	View filing
SC 13D/A	Jun 26, 2026	Jun 26, 2026	View filing
SC 13D/A	Jun 26, 2026	Jun 26, 2026	View filing
SC 13D/A	Jun 26, 2026	Jun 26, 2026	View filing
S-3	Jun 26, 2026	Jun 26, 2026	View filing
8-K	Jun 24, 2026	Jun 24, 2026	View filing
PRE 14A	Jun 22, 2026	Jun 22, 2026	View filing
8-K	Jun 5, 2026	Jun 5, 2026	View filing
10-Q	May 15, 2026	May 15, 2026	View filing
8-K	May 15, 2026	May 15, 2026	View filing
SC 13D/A	Apr 29, 2026	Apr 29, 2026	View filing
8-K/A	Apr 24, 2026	Apr 24, 2026	View filing
8-K	Apr 23, 2026	Apr 22, 2026	View filing
3	Apr 20, 2026	Apr 20, 2026	View filing
SC 13G/A	Apr 6, 2026	Apr 6, 2026	View filing

SEC Filings

Recent Filings